vimarsana.com

Page 6 - Automated Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hemostemix Inc : Hemostemix Announces Closing of UNIT Private Placement

Calgary, Alberta (Newsfile Corp. - February 28, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") announces that it has closed its previously announced non-brokered private

Thomas smeenkRegulation service providerCommon shares of the companyWorld economic forum technology pioneer awardHemostemix incAlberta newsfile corpVenture exchangeCompany common shareEach unitCommon shareCommon sharesMultilateral instrumentMinority security holdersSpecial transactionsIschemic cardiomyopathyDilated cardiomyopathy

The lab products that have earned Seals of Quality

We reveal the latest products to earn these coveted awards based on exceptional reviewer feedback

United statesElias malekSamita sainiMalvern panalyticalThomas macmurroughManas agrawalInstitut catalAlejandro capapTessa shatesKerry parkerUniversity of californiaUniversity of nevadaIndian institute of technology roparTexas tech university health sciences centerZymo researchEditorial article

The lab products that have earned Seals of Quality

We reveal the latest products to earn these coveted awards based on exceptional reviewer feedback

United statesElias malekSamita sainiMalvern panalyticalThomas macmurroughManas agrawalInstitut catalAlejandro capapTessa shatesKerry parkerUniversity of californiaUniversity of nevadaIndian institute of technology roparTexas tech university health sciences centerZymo researchEditorial article

Hemostemix Inc : Hemostemix Announces Financing

Calgary, Alberta (Newsfile Corp. - February 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce a non-brokered private placement of up to 7,200

Thomas smeenkAlberta securities commission ruleRegulation service providerWorld economic forum technology pioneer awardHemostemix incAlberta newsfile corpVenture exchangeCompany common shareEach unitCommon shareCommon sharesMultilateral instrumentMinority security holdersSpecial transactionsExisting security holdersIschemic cardiomyopathy

Hemostemix Inc : Hemostemix Partners with My Next Health, Obtains USD $150,000 Subscription at CAD $0 25 Per Unit, and Incorporates Functional Genomics

Calgary, Alberta (Newsfile Corp. - January 21, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce it has signed a Global Master Services

Thomas smeenkRichard heinzlRegulation service providerWorld economic forum technology pioneer awardHemostemix incMy next health incMy next healthAlberta newsfile corpGlobal master services agreementVenture exchangeNext healthIschemic cardiomyopathyStem cell treatmentRegulating stem cellsVitro techniquesStem cells

vimarsana © 2020. All Rights Reserved.